−0.029AUD
−7.13 MAUD
618.57 KAUD
120.48 M
About EXOPHARM LIMITED
Sector
CEO
Ian Dixon
Headquarters
Camberwell
Website
Founded
2013
ISIN
AU0000030975
FIGI
BBG00MJ66TB5
Exopharm Ltd. engages in the research and development of biopharmaceutical drugs. The company was founded by Ian Dixon and Gregor Lichtfuss in 2013 and is headquartered in Camberwell, Australia.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of EX1 is 0.011 AUD — it has increased by 10.00% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange EXOPHARM LIMITED stocks are traded under the ticker EX1.
EX1 stock is 9.09% volatile and has beta coefficient of 0.07. Check out the list of the most volatile stocks — is EXOPHARM LIMITED there?
Yes, you can track EXOPHARM LIMITED financials in yearly and quarterly reports right on TradingView.
EX1 net income for the last quarter is −1.61 M AUD, while the quarter before that showed −2.71 M AUD of net income which accounts for 40.53% change. Track more EXOPHARM LIMITED financial stats to get the full picture.
Today EXOPHARM LIMITED has the market capitalization of 4.83 M, it has increased by 10.00% over the last week.
No, EX1 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, EX1 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade EXOPHARM LIMITED stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So EXOPHARM LIMITED technincal analysis shows the buy rating today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating EXOPHARM LIMITED stock shows the sell signal. See more of EXOPHARM LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.